Radioimmunoassay for guanosine 3', 5'-cyclic phosphate (cGMP)
Liu, J.S.; Li, Y.M.; Wang, Z.G.; Wang, X.B.; Qi, P.; Jiang, C.H.; Cheng, G.F.; Chen, X.G.
Zhongguo Yao Li Xue Bao 2(1): 67-70
1981
ISSN/ISBN: 0253-9756 PMID: 6278829 Document Number: 177804
Document emailed within 1 workday
Related Documents
Nedvídková, J.; Felt, V. 1984: Plasma levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in patients with thyropathies Casopis Lekaru Ceskych 123(27): 835-837Polson, J.B.; Krzanowski, J.J.; Szentivanyi, A. 1974: Histamine induced changes in pulmonary guanosine-3',5'-cyclic monophosphate (cGMP) and adenosine-3',5'-cyclic monophosphate (cAMP) levels in mice following sensitization by Bordetella pertussis and/or propranolol Research Communications in Chemical Pathology and Pharmacology 9(2): 243-251
Mailman, R.B.; Frye, G.D.; Mueller, R.A.; Breese, G.R. 1979: Change in brain guanosine 3',5'-monophosphate (cGMP) content by thyrotropin-releasing hormone Journal of Pharmacology and Experimental Therapeutics 208(2): 169-175
Fikus, M.; Kwast=Welfeld, J.; Kazimierczuk, Z.; Shugar, D. 1974: Biochemical studies on some new analogues of adenosine-3'5'-cyclic phosphate, including isoguanosine-3 ,5-cylic phosphate Acta Biochimica Polonica 21(4): 465-474
Kornilova, E.S.; Kudriavtseva, N.V.; Nikol'skiĭ, N.N. 1985: Uptake of cyclic guanosine-3',5'-monophosphate and its metabolism in 3T6 cells Tsitologiia 27(8): 916-920
Miyagi, Y. 1979: Guanosine 3', 5'-cyclic monophosphate level in plasma of patients with cancer and various diseases Bulletin of Tokyo Medical and Dental University 26(2): 81-84
Schmidt, M.J.; Sawyer, B.D.; Truex, L.L.; Marshall, W.S.; Fleisch, J.H. 1985: LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphate Journal of Pharmacology and Experimental Therapeutics 232(3): 764-769
Baudouy, P.Y.; Abassade, P.; Valleteau de Moulliac, M.; Michel, J.B. 1991: Evaluation of urinary excretion of cyclic guanosine monophosphate in clinical cardiology Archives des Maladies du Coeur et des Vaisseaux 84(6): 777-784
Abdullaev, S.Kh.; Vorotyntseva, N.V.; Melekhov, V.I. 1987: Changes in the indices of cyclic nucleotides (cAMP and cGMP) in the blood plasma of children with acute intestinal infections Pediatriia 1987(4): 95
Li, X.-Q.; Jia, X.-B.; Cao, X.-P.; Yu, H.; Zhang, Y. 2006: Regulation of nitric oxide-cyclic guanosine monophosphate pathway on cochlear sensitivity Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 41(7): 532-536
Jakob, G.; Mair, J.; Vorderwinkler, K.P.; Judmaier, G.; König, P.; Zwierzina, H.; Pichler, M.; Puschendorf, B. 1994: Clinical significance of urinary cyclic guanosine monophosphate in diagnosis of heart failure Clinical Chemistry 40(1): 96-100
Kul'chitskiĭ, O.K. 1980: Effect of acetylcholine on cyclic guanosine monophosphate levels in the hearts of rats of different ages Biulleten' Eksperimental'noi Biologii i Meditsiny 90(9): 318-319
Xiao, X.C.; Tao, L.J. 2001: Assessment of dry body-weight in hemodialysis patients by plasma cyclic 3'5'-guanosine monophosphate Hunan Yi Ke da Xue Xue Bao 26(2): 133-135
Hunt, W.A.; Redos, J.D.; Dalton, T.K.; Catravas, G.N. 1977: Alterations in brain cyclic guanosine 3':5'-monophosphate levels after acute and chronic treatment with ethanol Journal of Pharmacology and Experimental Therapeutics 201(1): 103-109
Frey, E.A.; McIsaac, R.J. 1981: A comparison of cyclic guanosine 3':5'-monophosphate and muscarinic excitatory responses in the superior cervical ganglion of the rat Journal of Pharmacology and Experimental Therapeutics 218(1): 115-121
O'Callaghan, J.P.; Chess, Q.; McKimmey, C.; Clouet, D.H. 1979: The effects of opiates on the levels of cyclic 3':5'-guanosine monophosphate in discrete areas of the rat central nervous system Journal of Pharmacology and Experimental Therapeutics 210(3): 361-367
Rabkin, S.W.; Ohmae, M.; Klass, D.J. 1982: Antiarrhythmic effects of cyclic guanosine 3' :5'-monophosphate and sodium nitroprusside on barium chloride arrhythmias in rabbits Archives Internationales de Pharmacodynamie et de Therapie 257(2): 225-238
Murad, F.; Murad, F. 1996: The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate JAMA 276(14): 1189-1192
Drewett, J.G.; Ziegler, R.J.; Marchand, G.R.; Trachte, G.J. 1989: Cyclic guanosine 3',5' monophosphate mediates the inhibitory effect of atrial natriuretic factor in adrenergic, neuronal pheochromocytoma cells Journal of Pharmacology and Experimental Therapeutics 250(2): 428-432
Widecka, K.; Krzyzanowska-Swiniarska, B.; Ciechanowski, K.; Goździk, J.; Czekalski, S. 1993: Plasma concentrations of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with hyperthyroidism before and after short-term treatment with methimazole Endokrynologia Polska 44(1): 65-71